tirzepatide fda news Lilly's weight-loss drug removed from FDA's shortage list Huge news: FDA has approved

But, use it carefully and mix it with honey to avoid skin irritation

Nat Genet (2011) 43:24652

Fewer intact microtubules are available to faithfully orchestrate the process of meiotic chromosome segregation in the oocyte (65)

ADA: Lilly makes its case for oral GLP-1 orforglipron A first look at the phase 3 data with Eli Lilly's oral GLP-1 agonist orforglipron reveals encouraging blood sugar control data in patients with type 2 diabetes, and a side-effect profile free of the liver toxicity that scuppered rival candidates from Pfizer

PALMITOYL-ETHANOL-AMIDE (PEA)

[1] [2] For proper administration, the standard technique involves placing the pen base flat against the skin at a perpendicular (90-degree) angle